
1. plos one. 2009 oct 13;4(10):e7254. doi: 10.1371/journal.pone.0007254.

human papillomavirus-16 e7 interacts glutathione s-transferase p1 and
enhances role cell survival.

mileo am(1), abbruzzese c, mattarocci s, bellacchio e, pisano p, federico a,
maresca v, picardo m, giorgi a, maras b, schinin√† me, paggi mg.

author information: 
(1)department development therapeutic programs, crs, regina elena cancer
institute, rome, italy.

background: human papillomavirus (hpv)-16 paradigm "high-risk" hpvs, the
causative agents virtually cervical carcinomas. hpv e6 e7 viral genes 
are usually expressed tumors, suggesting key roles gene
products, e6 e7 oncoproteins, inducing malignant transformation.
methodology/principal findings: protein-protein interaction analysis, using
mass spectrometry, identified glutathione s-transferase p1-1 (gstp1) a
novel cellular partner hpv-16 e7 oncoprotein. following mapping the
region hpv-16 e7 sequence involved interaction, we
generated three-dimensional molecular model complex hpv-16 e7
and gstp1, used engineer mutant molecule hpv-16 e7 strongly
reduced affinity gstp1.when expressed hacat human keratinocytes, hpv-16 e7
modified equilibrium oxidized reduced forms gstp1, thereby
inhibiting jnk phosphorylation ability induce apoptosis. using
gstp1-deficient mcf-7 cancer cells sirna interference targeting gstp1 in
hacat keratinocytes expressing either wild-type mutant hpv-16 e7, uncovered
a pivotal role gstp1 pro-survival program elicited binding with
hpv-16 e7.
conclusions/significance: study provides evidence the
transforming abilities oncoprotein, setting groundwork devising
unique molecular tools interfere interaction between
hpv-16 e7 gstp1 minimize survival hpv-16 e7-expressing cancer
cells.

doi: 10.1371/journal.pone.0007254 
pmcid: pmc2758704
pmid: 19826491  [indexed medline]

